GlassScriptPhysician profile
Marcos Rosado
NPI 1902326846
$1,722.49
in general payments reported to CMS, 2019-2025
13 companies · $552 in 2025
The $552 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $189 · 2022: $422 · 2023: $83.42 · 2024: $476 · 2025: $552.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,111.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $372.42 | 2024-2025 | |
| Ethicon US, LLC | $276.87 | 2023-2025 | Vistaseal, Echelon Flex, Harmonic |
| Baudax Bio INC. | $227.51 | 2022 | |
| Polarityte, INC. | $188.58 | 2019 | |
| Abbvie INC. | $168.03 | 2024-2025 | |
| Tela Bio, INC. | $146.74 | 2022 | |
| Kerecis Limited | $110.99 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Takeda Pharmaceuticals U.S.A., INC. | $92.86 | 2023-2025 | Gattex |
| Alk-Abello, INC | $47.70 | 2022 | |
| Davol INC. | $34.00 | 2024 | Phasix Mesh |
| Hologic Sales and Service, LLC | $21.65 | 2024 | Coolseal Generator |
| Myriad Genetic Laboratories, INC. | $20.11 | 2025 | Myrisk |
| Organogenesis INC. | $15.03 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcos Rosado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.